Human PDSS2 = "All trans-polyprenyl-diphosphate synthase PDSS2" / decaprenyl-diphosphate
synthase subunit 2 (a.k.a. DLP1, hDLP1, C6orf210). HGNC:23041. Gene on chr 6q21.
A second, "by similarity" catalytic activity to all-trans-nonaprenyl diphosphate
(Q9 chain) is annotated by similarity to the mouse ortholog Q33DR3
[file:human/PDSS2/PDSS2-uniprot.txt]; humans predominantly make Q10.
Subunit / complex. UniProt SUBUNIT: "Heterotetramer composed of 2 PDSS1/DPS1
and 2 PDSS2/DLP1 subunits" (ECO:0000269|PubMed:16262699)
[file:human/PDSS2/PDSS2-uniprot.txt]. The functional enzyme is the PDSS1:PDSS2
2:2 heterotetramer; neither subunit is catalytically active alone. This is
GO:0032478 "heterotetrameric polyprenyl diphosphate synthase complex" (OLS def:
"a heterotetrameric complex ... In S. pombe it is a heterotetramer of Dlp1 and
Dps1"). The PDSS2 IPI "protein binding" annotation (WITH UniProtKB:Q5T2R2 = PDSS1)
is simply this heterodimeric partnership, so the informative representation is the
named complex, not bare "protein binding".
Primary evidence (PMID:16262699, Saiki et al. 2005, FEBS J). Abstract-only in
our cache (full_text_available: false). Abstract shows: mammalian long-chain
trans-prenyl diphosphate synthases "are heterotetramers composed of newly
characterized hDPS1 (mSPS1) and hDLP1 (mDLP1)"; co-expression of hDPS1 and hDLP1 in
E. coli produced Q10 and "an in vitro activity of solanesyl or decaprenyl
diphosphate synthase was verified"; gel filtration indicates "they consist of
heterotetramers"; and heterologous mSPS1+hDLP1 / hDPS1+mDLP1 combinations gave both
Q9 and Q10, "indicating both components are involved in determining the ubiquinone
side chain" PMID:16262699. hDLP1 = PDSS2. So PDSS2 both is a complex subunit and
is required for chain-length determination, but the catalytic activity is a
complex-level property (hence GOA uses contributes_to for the MF and part_of
for the complex).
Pathway. UniProt PATHWAY: "Cofactor biosynthesis; ubiquinone biosynthesis"
(ECO:0000269|PubMed:16262699) [file:human/PDSS2/PDSS2-uniprot.txt]. BP =
GO:0006744 ubiquinone biosynthetic process. isoprenoid biosynthetic process
(GO:0008299) is a true but more general parent process.
Localization. UniProt SUBCELLULAR LOCATION: "Mitochondrion"
(ECO:0000269|PubMed:34800366) [file:human/PDSS2/PDSS2-uniprot.txt]. Reactome places
the reaction in the mitochondrial matrix (GO:0005759). The N-terminal sequence
(MNFRQLLLHLPRYLGASGSPRRLWWSPS...) is consistent with a mitochondrial-targeting
presequence. Substrates FPP/IPP are made in the cytosol and imported (Reactome:
"IPPP and FPP are provided by cytosolic cholesterol biosynthesis. However, the
means of transport of FPP and IPPP into mitochondria is unknown"
[reactome/R-HSA-2162253]). A single-antibody HPA IDA to cytosol (GO:0005829)
conflicts with the mitochondrial matrix consensus and is treated as an
over-annotation (not removed — it is IDA).
Disease. UniProt DISEASE: "Coenzyme Q10 deficiency, primary, 3 (COQ10D3)
[MIM:614652]: A fatal encephalomyopathic form of coenzyme Q10 deficiency with
nephrotic syndrome" (ECO:0000269|PubMed:17186472)
[file:human/PDSS2/PDSS2-uniprot.txt]. The reported patient (Leigh syndrome with
nephropathy) is the S382L variant (VAR_055398, PMID:17186472). The disease
underscores the essential role of the PDSS1/PDSS2 enzyme in CoQ10 biosynthesis.
PMID:17186472 is NOT cached locally (abstract not read); disease role stated only
from the UniProt DISEASE block.
Family. UniProt SIMILARITY: "Belongs to the FPP/GGPP synthase family"; Pfam
PF00348 polyprenyl_synt; InterPro IPR000092. PANTHER subfamily PTHR12001:SF55 "ALL
TRANS-POLYPRENYL-DIPHOSPHATE SYNTHASE PDSS2".